Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate

Michael Brawer, MD
Published: Wednesday, Aug 16, 2017



Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

This was significant because we are moving more towards the utilization of active surveillance in the United States, explains Brawer. With the statistics involving African Americans, it is important to know whether tests are reliable. With respect to Prolaris, it was necessary to determine if the test worked for all patient populations, states Brawer.



Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

This was significant because we are moving more towards the utilization of active surveillance in the United States, explains Brawer. With the statistics involving African Americans, it is important to know whether tests are reliable. With respect to Prolaris, it was necessary to determine if the test worked for all patient populations, states Brawer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x